Celldex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CLDX Key Statistics
Stock Snapshot
As of today, Celldex(CLDX) shares are valued at $26.83. The company's market cap stands at 1.78B, with a P/E ratio of -7.93.
During the trading session on 2025-12-25, Celldex(CLDX) shares reached a daily high of $26.95 and a low of $26.39. At a current price of $26.83, the stock is +1.7% higher than the low and still -0.4% under the high.
Trading activity shows a volume of 212.08K, compared to an average daily volume of 692.96K.
Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $30.50 and a low of $14.40.
Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $30.50 and a low of $14.40.
CLDX News
Investors in Celldex Therapeutics, Inc. (Symbol: CLDX) saw new options become available this week, for the August 2026 expiration. One of the key data points th...
In December 2025, Celldex Therapeutics began a global Phase 3 EMBARQ-ColdU and SD trial of barzolvolimab in adults with cold urticaria and symptomatic dermograp...
Celldex Therapeutics (CLDX) has been back on traders radar after a recent bump in the share price, leaving many investors wondering whether this clinical stage...